Distinct dopaminergic personality patterns in patients with prolactinomas: A comparison with nonfunctioning pituitary adenoma patients and age-and gender-matched controls

Neuroendocrinology

Volumn 96, Issue 3, 2012, Pages 204-211

  Athanasoulia, A P ^a   Ising, M ^a   Pfister, H ^a   Mantzoros, C S ^b,c   Stalla, G K ^a   Sievers, C ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Dopamine; Nonfunctioning pituitary adenomas; Personality; Pituitary; Prolactinoma

Indexed keywords

ADULT; ARTICLE; ASTHENIA; AVOIDANCE BEHAVIOR; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPENDENT PERSONALITY DISORDER; EMOTIONAL ATTACHMENT; EXTRAVERSION; FATIGUE; FEMALE; HUMAN; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; NEUROSIS; NONFUNCTIONING PITUITARY ADENOMA; PERSONALITY; PESSIMISM; PRIORITY JOURNAL; PROLACTINOMA; PSYCHOSIS; QUESTIONNAIRE; SOCIAL BEHAVIOR; UNCERTAINTY;

ADULT; AGED; DOPAMINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PERSONALITY; PITUITARY NEOPLASMS; PROLACTINOMA; QUESTIONNAIRES;

EID: 84870243295     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000335996     Document Type: Article

References (39)

1. Weitzner MA: Neuropsychiatry and pituitary disease: An overview. Psychother Psychosom 1998; 67: 125-132. (Pubitemid 28291334)
2. Tiemensma J, Kaptein AA, Pereira AM, Smit JW, Romijn JA, Biermasz NR: Coping strategies in patients after treatment for functioning or nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 2011;96: 964-971.
3. Sievers C, Dimopoulou C, Pfister H, Lieb R, Steffin B, Roemmler J, Schopohl J, Mueller M, Schneider HJ, Ising M, Wittchen HU, Stalla GK: Prevalence of mental disorders in acromegaly: A cross-sectional study in 81 acromegalic patients. Clin Endocrinol (Oxf) 2009; 71: 691-701.
4. Sievers C, Ising M, Pfister H, Dimopoulou C, Schneider HJ, Roemmler J, Schopohl J, Stalla GK: Personality in patients with pituitary adenomas is characterized by increased anxiety-related traits: Comparison of 70 acromegalic patients with patients with non-functioning pituitary adenomas and age- And gender-matched controls. Eur J Endocrinol 2009; 160: 367-373.
5. Tiemensma J, Biermasz NR, van der Mast RC, Wassenaar MJ, Middelkoop HA, Pereira AM, Romijn JA: Increased psychopathology and maladaptive personality traits, but normal cognitive functioning, in patients after long-Term cure of acromegaly. J Clin Endocrinol Metab 2010; 95:E392-E402.
6. Sonino N, Fava GA: Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment. CNS Drugs 2001; 15: 361-373. (Pubitemid 32487993)
7. Tiemensma J, Biermasz NR, Middelkoop HA, van der Mast RC, Romijn JA, Pereira AM: Increased prevalence of psychopathology and maladaptive personality traits after long-Term cure of Cushing's disease. J Clin Endocrinol Metab 2010; 95:E129-E141.
8. Tiemensma J, Kokshoorn NE, Biermasz NR, Keijser BJ, Wassenaar MJ, Middelkoop HA, Pereira AM, Romijn JA: Subtle cognitive impairments in patients with long-Term cure of Cushing's disease. J Clin Endocrinol Metab 2010; 95: 2699-2714.
9. Sonino N, Bonnini S, Fallo F, Boscaro M, Fava GA: Personality characteristics and quality of life in patients treated for Cushing's syndrome. Clin Endocrinol (Oxf) 2006; 64: 314-318.
10. Sobrinho LG: Emotional aspects of hyperprolactinemia. Psychother Psychosom 1998; 67: 133-139. (Pubitemid 28291335)
11. Kars M, van der Klaauw AA, Onstein CS, Pereira AM, Romijn JA: Quality of life is decreased in female patients treated for microprolactinoma. Eur J Endocrinol 2007; 157: 133-139. (Pubitemid 47233116)
12. van der Klaauw AA, Kars M, Biermasz NR, Roelfsema F, Dekkers OM, Corssmit EP, van Aken MO, Havekes B, Pereira AM, Pijl H, Smit JW, Romijn JA: Disease-specific impairments in quality of life during long-Term follow-up of patients with different pituitary adenomas. Clin Endocrinol (Oxf) 2008; 69: 775-784.
13. Rocco A, Mori F, Baldelli R, Aversa A, Munizzi MR, Nardone MR, Fabbrini A, Falaschi P: Effect of chronic bromocriptine treatment on psychological profile of patients with PRL-secreting pituitary adenomas. Psychoneuroendocrinology 1993; 18: 57-66. (Pubitemid 23080624)
14. Cloninger CR: A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr Dev 1986; 4: 167-226. (Pubitemid 17216108)
15. Ben-Jonathan N, Hnasko R: Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 2001; 22: 724-763. (Pubitemid 34214293)
16. Xia P, Shi YF: Evaluation of hypothalamic dopaminergic function in patients with pituitary prolactinoma. Proc Chin Acad Med Sci Peking Union Med Coll 1989; 4: 121-125.
17. Wittchen HU, Pfister H: Dia-x-Interviews: Manual für Screening-Verfahren und interview. Frankfurt, Swets & Zeitlinger, 1997.
18. Heck A, Lieb R, Unschuld PG, Ellgas A, Pfister H, Lucae S, Erhardt A, Himmerich H, Horstmann S, Kloiber S, Ripke S, Muller-Myhsok B, Bettecken T, Uhr M, Holsboer F, Ising M: Evidence for associations between PDE4D polymorphisms and a subtype of neuroticism. Mol Psychiatry 2008; 13: 831-832.
19. Eysenck SB, Eysenck HJ: Impulsiveness and venturesomeness: Their position in a dimensional system of personality description. Psychol Rep 1978; 43: 1247-1255.
20. Weyers P, Krebs H, Janke W: Reliability and construct-validity of the German version of Cloninger's tridimensional personality questionnaire. Pers Individ Diff 1995; 19: 853-861.
21. Heck A, Lieb R, Ellgas A, Pfister H, Lucae S, Roeske D, Putz B, Muller-Myhsok B, Uhr M, Holsboer F, Ising M: Investigation of 17 candidate genes for personality traits confirms effects of the HTR2A gene on novelty seeking. Genes Brain Behav 2009; 8: 464-472.
22. Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JA: Diagnosis and treatment of hyperprolactinemia: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011;96: 273-288.
23. Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I, Stalla GK, Ghigo E: Hypopituitarism. Lancet 2007; 369: 1461-1470. (Pubitemid 46635784)
24. Quigley ME, Yen SS: Evidence for increased dopaminergic inhibition of secretion of thyroid-stimulating hormone in hyperprolactinemic patients with pituitary microadenoma. Am J Obstet Gynecol 1980; 137: 653-655. (Pubitemid 10035903)
25. Scanlon MF, Rodriguez-Arnao MD, Mc-Gregor AM, Weightman D, Lewis M, Cook DB, Gomez-Pan A, Hall R: Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: Comparison with other tests of hypothalamic-pituitary function. Clin Endocrinol (Oxf) 1981; 14: 133-143. (Pubitemid 11053359)
26. Doknic M, Pekic S, Zarkovic M, Medic-Stojanoska M, Dieguez C, Casanueva F, Popovic V: Dopaminergic tone and obesity: An insight from prolactinomas treated with bromocriptine. Eur J Endocrinol 2002; 147: 77-84. (Pubitemid 34814743)
27. Cloninger CR: A systematic method for clinical description and classification of personality variants: A proposal. Arch Gen Psychiatry 1987; 44: 573-588. (Pubitemid 17082099)
28. Gerra G, Zaimovic A, Timpano M, Zambelli U, Delsignore R, Brambilla F: Neuroendocrine correlates of temperamental traits in humans. Psychoneuroendocrinology 2000; 25: 479-496. (Pubitemid 30249193)
29. Tomer R, Aharon-Peretz J: Novelty seeking and harm avoidance in Parkinson's disease: Effects of asymmetric dopamine deficiency. J Neurol Neurosurg Psychiatry 2004; 75: 972-975. (Pubitemid 38869608)
30. Nicholas L, Dawkins K, Golden RN: Psychoneuroendocrinology of depression. Prolactin. Psychiatr Clin North Am 1998; 21: 341-358.
31. Smillie LD, Cooper AJ, Proitsi P, Powell JF, Pickering AD: Variation in DRD2 dopamine gene predicts extraverted personality. Neurosci Lett 2010; 468: 234-237.
32. Golimbet VE, Alfimova MV, Gritsenko IK, Ebstein RP: Relationship between dopamine system genes and extraversion and novelty seeking. Neurosci Behav Physiol 2007; 37: 601-606. (Pubitemid 47322131)
33. Weintraub D: Impulse control disorders in Parkinson's disease: Prevalence and possible risk factors. Parkinsonism Relat Disord 2009; 15(suppl 3):S110-S113.
34. Falhammar H, Yarker JY: Pathological gambling and hypersexuality in cabergolinetreated prolactinoma. Med J Aust 2009; 190: 97.
35. Davie M: Pathological gambling associated with cabergoline therapy in a patient with a pituitary prolactinoma. J Neuropsychiatry Clin Neurosci 2007; 19: 473-474. (Pubitemid 350156112)
36. Heck A, Pfister H, Czamara D, Muller-Myhsok B, Putz B, Lucae S, Hennings J, Ising M: Evidence for associations between mdga2 polymorphisms and harm avoidance- replication and extension of a genome-wide association finding. Psychiatr Genet 2011; 21: 257-260.
37. Nunes MC, Sobrinho LG, Calhaz-Jorge C, Santos MA, Mauricio JC, Sousa MF: Psychosomatic factors in patients with hyperprolactinemia and/or galactorrhea. Obstet Gynecol 1980; 55: 591-595. (Pubitemid 10068258)
38. Sobrinho LG, Almeida-Costa JM: Hyperprolactinaemia as a result of immaturity or regression: The concept of maternal subroutine. A new model of psychoendocrine interactions. Psychother Psychosom 1992; 57: 128-132.
39. Sobrinho LG: Prolactin, psychological stress and environment in humans: Adaptation and maladaptation. Pituitary 2003; 6: 35-39. (Pubitemid 37455643)